INTEC PHARMA LTD JERUSALEM's ticker is and the CUSIP is M53644106. A total of 36 filers reported holding INTEC PHARMA LTD JERUSALEM in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $1,126,000 | -47.1% | 259,377 | -10.7% | 0.48% | -44.1% |
| Q1 2019 | $2,129,000 | -0.4% | 290,434 | +2.5% | 0.85% | -15.4% |
| Q4 2018 | $2,137,000 | +33.4% | 283,473 | 0.0% | 1.00% | +93.1% |
| Q3 2018 | $1,602,000 | +790.0% | 283,473 | +709.9% | 0.52% | +622.2% |
| Q4 2017 | $180,000 | – | 35,000 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 630,000 | $3,528,000 | 1.74% |
| DAFNA Capital Management LLC | 135,000 | $756,000 | 0.75% |
| Cormorant Asset Management, LP | 800,000 | $4,480,000 | 0.72% |
| Perceptive Advisors | 700,000 | $3,920,000 | 0.16% |
| SABBY MANAGEMENT, LLC | 613,910 | $3,438,000 | 0.14% |
| Ion Asset Management Ltd. | 10,000 | $56,000 | 0.08% |
| JANE STREET GROUP, LLC | 34,317 | $194,000 | 0.00% |
| UBS Group AG | 1,296 | $7,000 | 0.00% |